Economic analysis of alternative pembrolizumab and nivolumab dosing strategies at an academic cancer center. Hall, E., Zhang, J., Kim, E., Hwang, G., Bhatia, S., Reddy, S. A. AMER SOC CLINICAL ONCOLOGY. 2019

View details for DOI 10.1200/JCO.2019.37.15_suppl.6504

View details for Web of Science ID 000487345806058